Product image of Inipomp (Pantoprazole) supplied by GNH India

Inipomp

Active Ingredient:
Pantoprazole
Origin:
EU

Inipomp (Pantoprazole)

Pantoprazole, the active ingredient in Inipomp, is a proton pump inhibitor presented as an intravenous solution for intravenous use. It reduces gastric acid secretion by inhibiting the H+/K+ ATPase in parietal cells, thereby treating acid‑related conditions such as gastroesophageal reflux disease, erosive esophagitis, peptic ulcer disease, and helping to prevent NSAID‑induced gastric ulcers in hospitalized patients.

GNH India supplies Inipomp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product meets European Union quality standards and is distributed under strict Good Distribution Practice guidelines.

Manufacturer / TM Owner

Takeda France Sas

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Pantoprazole is used to manage acid‑related gastrointestinal disorders by decreasing gastric acid production.

  • Gastroesophageal reflux disease (GERD): reduces reflux symptoms and promotes healing of esophageal irritation.
  • Erosive esophagitis: facilitates mucosal healing and prevents progression of ulceration.
  • Peptic ulcer disease: promotes ulcer healing and reduces risk of recurrence.
  • Prevention of NSAID‑induced gastric ulcers: protects the gastric lining in patients receiving non‑steroidal anti‑inflammatory drugs.

How It Works

  • Pantoprazole selectively and irreversibly inhibits the H+/K+ ATPase enzyme, also known as the gastric proton pump, located on the secretory surface of gastric parietal cells. By blocking this final step of acid secretion, it markedly reduces both basal and stimulated gastric acid output, leading to an increase in gastric pH and improves symptom control in acid‑related conditions.

Side Effects

Pantoprazole may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Headache: mild pain or pressure in the head.
  • Diarrhea: loose, watery stools.
  • Nausea: feeling of sickness or urge to vomit.
  • Abdominal pain: discomfort or cramping in the stomach area.

Serious or Rare Side Effects

  • Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing.
  • Clostridioides difficile infection: severe diarrhea with abdominal pain and fever.
  • Liver enzyme elevation: signs of hepatic dysfunction such as jaundice.

Precautions & Warnings

When using Inipomp, consider the following precautions to ensure safe therapy.

  • Assess renal and hepatic function: adjust therapy if impairment is present.
  • Monitor electrolytes: especially magnesium and potassium during prolonged use.
  • Use the lowest effective dose: limit duration to the shortest period required.
  • Caution in patients with known hypersensitivity to pantoprazole or other PPIs.
  • Avoid abrupt discontinuation: taper to reduce rebound acid hypersecretion.
  • Store at controlled room temperature: keep in original packaging, protect from light and moisture.

Avoid Interactions

Pantoprazole can interact with several medicines; awareness of the interaction level helps guide clinical decisions.

Major Interactions (Avoid)

  • Clopidogrel: reduced antiplatelet effect.
  • Ketoconazole, itraconazole, and other azole antifungals: decreased absorption due to higher gastric pH.
  • Atazanavir and rilpivirine (HIV protease inhibitors): reduced drug exposure.

Moderate Interactions (Monitor Closely)

  • Warfarin: possible increased INR, monitor coagulation.
  • Digoxin: increased serum levels, monitor for toxicity.
  • Methotrexate: reduced clearance, monitor renal function and levels.

Frequently Asked Questions

Inipomp is an intravenous formulation of pantoprazole indicated for the treatment of acid‑related gastrointestinal conditions such as gastroesophageal reflux disease, erosive esophagitis, peptic ulcer disease, and for the prevention of gastric ulcers associated with non‑steroidal anti‑inflammatory drug therapy.

Pantoprazole works by selectively and irreversibly inhibiting the H+/K+ ATPase enzyme (the gastric proton pump) on the secretory surface of parietal cells, which blocks the final step of gastric acid secretion, thereby raising gastric pH and allowing damaged mucosa to heal.

The appropriate dose of Inipomp is determined by the prescribing clinician based on the specific indication, patient condition, and clinical response. Dosage recommendations are provided in the product labeling and should be individualized for each patient.

Safety data for pantoprazole in pregnancy and lactation are limited. The drug should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus, and breastfeeding mothers should consult their healthcare provider before use.

To order Inipomp, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and necessary import documentation.

Inipomp (pantoprazole) belongs to the proton pump inhibitor class, offering more potent and longer‑lasting acid suppression compared with H2‑receptor antagonists. Among PPIs, pantoprazole has a favorable interaction profile and is often preferred for intravenous use in acute care settings.

Inipomp should be stored at controlled room temperature, kept in its original packaging, and protected from light and moisture. The solution should be inspected for particulate matter before administration and used according to aseptic technique.

Inipomp is administered by intravenous infusion. The exact infusion rate and duration are determined by the prescribing clinician and should follow the product’s prescribing information and institutional protocols.

Serious risks include severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated diarrhea, and hepatic dysfunction manifested by elevated liver enzymes or jaundice. Patients should be monitored for signs of these events, especially during prolonged therapy.

Inipomp should be avoided in patients with known hypersensitivity to pantoprazole or any other proton pump inhibitor. Caution is also advised for individuals with severe hepatic impairment, and it should be used only under medical supervision in pregnant or lactating women.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Pantoprazole

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT